Civic Intelligence

Target Als Foundation Inc.

990PF • Fiscal year 2015 • EIN 81-0756743

Jan 01, 2015 to Dec 31, 2015

New York, NY
Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

80th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2015 filings • NTEE B82 • <$500k nonprofits • Source year 2015

Liabilities / Revenue

80th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

2015 filings • NTEE B82 • <$500k nonprofits • Source year 2015

Net Margin

99th percentile

100%

Higher net margin than 99% of similar nonprofits.

2015 filings • NTEE B82 • <$500k nonprofits • Source year 2015

Top Officer Pay

Score unavailable

No value available

This filing does not contain officer compensation rows.

Source year 2015

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2015

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2015

Assets

$1

No earlier filing loaded for comparison.

Net Assets

-

No earlier filing loaded for comparison.

Liabilities

$0

No earlier filing loaded for comparison.

Revenue

$1

No earlier filing loaded for comparison.

Expenses

$0

No earlier filing loaded for comparison.

Net Income

$1

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$200M$150M$100M$50M$0Assets 2015: $1Liabilities 2015: $02015Assets 2019: $5,760,183Liabilities 2019: $217,296Net Assets 2019: $5,542,8872019Assets 2020: $27,026,641Liabilities 2020: $1,189,047Net Assets 2020: $25,837,5942020Assets 2021: $26,527,264Liabilities 2021: $1,501,602Net Assets 2021: $25,025,6622021Assets 2022: $115,562,468Liabilities 2022: $1,749,390Net Assets 2022: $113,813,0782022Assets 2023: $180,572,961Liabilities 2023: $3,048,779Net Assets 2023: $177,524,1822023Assets 2024: $128,911,762Liabilities 2024: $4,351,675Net Assets 2024: $124,560,0872024

Highlighted filing

2015

Assets$1
Liabilities$0
Net Assets-

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$100M$50M$0-$50MRevenue 2015: $1Expenses 2015: $0Net Income 2015: $12015Revenue 2019: $5,489,621Expenses 2019: $5,462,803Net Income 2019: $26,8182019Revenue 2020: $27,270,423Expenses 2020: $7,004,450Net Income 2020: $20,265,9732020Revenue 2021: $6,977,665Expenses 2021: $7,789,597Net Income 2021: -$811,9322021Revenue 2022: $98,381,069Expenses 2022: $9,271,989Net Income 2022: $89,109,0802022Revenue 2023: $79,570,641Expenses 2023: $15,859,537Net Income 2023: $63,711,1042023Revenue 2024: $51,745,776Expenses 2024: $27,108,058Net Income 2024: $24,637,7182024

Highlighted filing

2015

Revenue$1
Expenses$0
Net Income$1
Filing Detail Status

This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2015 to Dec 31, 2015
Mission and Program Overview

Mission

Our mission is to break down barriers to als research to find effective treatments. By uniting academia, the pharma and biotech industry, government, venture capital, related nonprofits, and the als community, we aim to overcome the challenges that have long hindered progress, bringing hope and tangible advancements to those affected by this devastating disease.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings